These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12826592)

  • 21. Pulmonary complications of sickle cell disease.
    Gladwin MT; Vichinsky E
    N Engl J Med; 2008 Nov; 359(21):2254-65. PubMed ID: 19020327
    [No Abstract]   [Full Text] [Related]  

  • 22. An update on arginine in sickle cell disease.
    Benites BD; Olalla-Saad ST
    Expert Rev Hematol; 2019 Apr; 12(4):235-244. PubMed ID: 30855194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rationale for IL-1beta targeted therapy for ischemia-reperfusion induced pulmonary and other complications in sickle cell disease.
    Wanderer AA
    J Pediatr Hematol Oncol; 2009 Aug; 31(8):537-8. PubMed ID: 19636265
    [No Abstract]   [Full Text] [Related]  

  • 24. Hemolytic anemia-associated pulmonary hypertension in sickle cell disease.
    Lin EE; Rodgers GP; Gladwin MT
    Curr Hematol Rep; 2005 Mar; 4(2):117-25. PubMed ID: 15720960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension.
    Ghofrani HA; Pepke-Zaba J; Barbera JA; Channick R; Keogh AM; Gomez-Sanchez MA; Kneussl M; Grimminger F
    J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):68S-72S. PubMed ID: 15194181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High levels of nitric oxide in individuals with pulmonary hypertension receiving epoprostenol therapy.
    Ozkan M; Dweik RA; Laskowski D; Arroliga AC; Erzurum SC
    Lung; 2001; 179(4):233-43. PubMed ID: 11891614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary hypertension in sickle cell disease.
    Lee MT; Rosenzweig EB; Cairo MS
    Clin Adv Hematol Oncol; 2007 Aug; 5(8):645-53, 585. PubMed ID: 17982405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sickle cell disease-associated pulmonary hypertension: a coat of many colors.
    McLaughlin VV; Channick R
    Am J Respir Crit Care Med; 2007 Jun; 175(12):1218-9. PubMed ID: 17545455
    [No Abstract]   [Full Text] [Related]  

  • 29. Fatal small-bowel necrosis and pulmonary hypertension in sickle cell disease.
    Hammond TG; Mosesson MW
    Arch Intern Med; 1989 Feb; 149(2):447-8. PubMed ID: 2916890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasodilators in patients with chronic obstructive pulmonary disease and pulmonary hypertension: not ready for prime time!
    Humbert M; Simonneau G
    Am J Respir Crit Care Med; 2010 Feb; 181(3):202-3. PubMed ID: 20093654
    [No Abstract]   [Full Text] [Related]  

  • 31. The proverbial chicken or the egg? Dissection of the role of cell-free hemoglobin versus reactive oxygen species in sickle cell pathophysiology.
    Krajewski ML; Hsu LL; Gladwin MT
    Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H4-7. PubMed ID: 18502905
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pulmonary hypertension: the role of nitric oxide in adults].
    Neidecker J
    Rev Esp Anestesiol Reanim; 2001 Dec; 48(10):457-9. PubMed ID: 11792299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of oral arginine supplementation on exhaled nitric oxide concentration in sickle cell anemia and acute chest syndrome.
    Sullivan KJ; Kissoon N; Sandler E; Gauger C; Froyen M; Duckworth L; Brown M; Murphy S
    J Pediatr Hematol Oncol; 2010 Oct; 32(7):e249-58. PubMed ID: 20724949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sickle cell anemia pathophysiology: back to the data.
    Eckman JR; Embury SH
    Am J Hematol; 2011 Feb; 86(2):121-2. PubMed ID: 21264895
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pulmonary hypertension in sickle cell disease--epidemiology, pathogenesis, diagnosis and treatment].
    Maschmeyer G; Haas A; Dickerhoff R; Kleber FX
    Dtsch Med Wochenschr; 2007 Jan; 132(3):103-7. PubMed ID: 17219345
    [No Abstract]   [Full Text] [Related]  

  • 36. Pathogenetic role of eNOS uncoupling in cardiopulmonary disorders.
    Gielis JF; Lin JY; Wingler K; Van Schil PE; Schmidt HH; Moens AL
    Free Radic Biol Med; 2011 Apr; 50(7):765-76. PubMed ID: 21172428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Sickle cell disease and life-threatening acute chest syndrome: Interest of extracorporeal life support].
    Grein E; Ducrocq N; Kimmoun A; Vanhuyse F; Gerard A; Levy B
    Ann Fr Anesth Reanim; 2012 Dec; 31(12):973-5. PubMed ID: 23159514
    [No Abstract]   [Full Text] [Related]  

  • 38. [Some aspects of clinical use of nitric oxide in pulmonary hypertension].
    Cheng X; He J
    Zhonghua Yi Xue Za Zhi; 1998 Jan; 78(1):6-7. PubMed ID: 10923395
    [No Abstract]   [Full Text] [Related]  

  • 39. Low micromolar intravascular cell-free hemoglobin concentration affects vascular NO bioavailability in sickle cell disease: a computational analysis.
    Deonikar P; Kavdia M
    J Appl Physiol (1985); 2012 Apr; 112(8):1383-92. PubMed ID: 22223452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sickle-cell anemia and pulmonary hypertension.
    Ninkovich GM; Miller SK; Alpert PT
    J Am Acad Nurse Pract; 2010 Apr; 22(4):198-204. PubMed ID: 20409257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.